HIV-1 Vpr increases HCV replication through VprBP in cell culture

Area of Science:

• Virology
• Hepatology
• Immunology

Background:

• Coinfection with HIV and HCV is common and worsens liver disease.
• The mechanism by which HIV promotes HCV liver disease is not fully understood.
• Previous research showed HIV-1 Vpr enhances HCV RNA replication.

Purpose of the Study:

• To investigate the role of host protein VprBP in Vpr-mediated enhancement of HCV replication.
• To elucidate the mechanism of HIV-1 Vpr's effect on HCV replication.

Main Methods:

• Used Vpr mutants deficient in VprBP binding.
• Utilized VprBP knockdown cells.
• Employed Cullin RING E3 ligase inhibitor MLN4924.

Main Results:

• A Vpr mutant unable to bind VprBP did not enhance HCV replication.
• VprBP knockdown significantly reduced Vpr's enhancement of HCV replication.
• Inhibition of Cullin RING E3 ligases impaired Vpr's function in HCV replication.

Conclusions:

• HIV-1 Vpr promotes HCV replication in a VprBP-dependent manner.
• Cullin RING E3 ligase activity is crucial for Vpr's function in HCV replication.
• HIV-1 Vpr may alter the host ubiquitination system to favor HCV replication.